Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised...

Area of Science:

• Oncology
• Molecular Biology
• Signal Transduction

Background:

• Epidermal growth factor receptor (EGFR) signaling pathways, including extracellular signal-regulated kinases (ERKs), Akt, and signal transducer and activator of transcription 3 (STAT3), are crucial in cancer development.
• Aberrant EGFR signaling is implicated in non-small-cell lung cancer (NSCLC) pathogenesis.

Purpose of the Study:

• To evaluate the expression levels of EGFR, p-ERK, p-Akt, and p-STAT3 in NSCLC specimens.
• To correlate EGFR expression with the activation of downstream signaling peptides.
• To investigate the association between these signaling molecules and clinicopathological factors, including tumor differentiation and relapse-free survival.

Main Methods:

• Immunohistochemistry was performed on 60 NSCLC tissue specimens.
• Expression levels of EGFR, phosphorylated ERK (p-ERK), phosphorylated Akt (p-Akt), and phosphorylated STAT3 (p-STAT3) were quantified.
• Statistical analyses were used to determine correlations between peptide expressions and clinicopathological parameters.

Main Results:

• EGFR overexpression was detected in 78% of NSCLC specimens.
• p-ERK, p-Akt, and p-STAT3 were expressed in 28%, 53%, and 58% of specimens, respectively.
• EGFR expression levels were significantly associated with p-ERK and p-Akt expression (P=0.045 and 0.020, respectively).
• p-Akt and p-STAT3 expression correlated with well-differentiated tumors (P=0.045 and 0.014, respectively).
• No significant impact on relapse-free survival was observed for any of the examined peptides.

Conclusions:

• Various signal transduction pathways are frequently involved in NSCLC.
• EGFR overexpression is associated with increased activation of downstream ERK and Akt pathways.
• These findings suggest a potential role for EGFR overexpression in driving downstream signaling activation in NSCLC.